| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Sudarshan Hebbar | Chief Medical Officer | 2026-06-25 | 124,486 | $0.80 | $99.96kBuy |
| A. Rachel Leheny | CHIEF EXECUTIVE OFFICER | 2026-06-25 | 186,729 | $0.80 | $149.94kBuy |
| Fred A. Middleton | Director | 2026-06-25 | 248,972 | $0.80 | $199.92kBuy |
| Eric W. Roberts | CHIEF BUSINESS OFFICER | 2026-06-25 | 186,729 | $0.80 | $149.94kBuy |
| Robert N. Wilson | Director | 2026-06-25 | 1,182,621 | $0.80 | $949.64kBuy |
| Eric W. Roberts | CHIEF BUSINESS OFFICER | 2025-09-18 | 2,500 | $3.07 | $7.68kBuy |
| Eric W. Roberts | CHIEF BUSINESS OFFICER | 2025-09-15 | 3,400 | $2.68 | $9.11kBuy |
| Eric W. Roberts | CHIEF BUSINESS OFFICER | 2025-09-12 | 5,000 | $3.12 | $15.60kBuy |
| Eric W. Roberts | CHIEF BUSINESS OFFICER | 2025-09-09 | 2,343 | $3.15 | $7.38kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| James E. Flynn | 77.35% | 5,281,713 | $11.62M | Insider |
| Alafi Capital Co LLC | 74.87% | 5,112,345 | $11.25M | Insider |
| Orbimed Advisors LLC | 60.97% | 4,163,347 | $9.16M | Insider |
| Fred A. Middleton | 49.85% | 3,404,222 | $7.49M | Insider |
| Sanderling Venture Partners VI Co Investment Fund LP | 35.25% | 2,407,172 | $5.30M | Insider |
| Sanderling Venture Partners VI LP | 33.97% | 2,319,428 | $5.10M | Insider |
| Evgeny Zaytsev | 30.95% | 2,113,513 | $4.65M | Insider |
| Clarus Lifesciences III LP | 28.27% | 1,930,395 | $4.25M | Insider |
| Christy L. Shaffer | 23.53% | 1,606,669 | $3.53M | Insider |
| Robert N. Wilson | 23.50% | 1,604,650 | $3.53M | Insider |